EU committee backs extending use of Lilly’s diabetes drug for children aged 10 and above
Dec 12 (Reuters) – The European Medicines Agency’s committee on Friday recommended extending the use of Eli Lilly’s blockbuster drug Mounjaro for the treatment of type 2 diabetes in adolescents and children aged 10 years and above. Treatment options for children with type 2 diabetes for controlling blood sugar had been limited to metformin and …
EU committee backs extending use of Lilly’s diabetes drug for children aged 10 and above Read More »










